Drug Information

Drug General Information
Drug ID
D0IA5O
Former ID
DIB011261
Drug Name
GSK-2241658A
Synonyms
NY-ESO-1 ASCI (melanoma), GSK; Recombinant NY-ESO-1 antigen immunotherapeutic vaccine (melanoma), GlaxoSmithKline; 2241658A
Drug Type
Vaccine
Indication Melanoma [ICD9: 172; ICD10:C43] Phase 1 [523193]
Company
GlaxoSmithKline plc
Target and Pathway
Target(s) NY-ESO-1 Target Info [523193]
References
Ref 523193ClinicalTrials.gov (NCT01213472) Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma. U.S. National Institutes of Health.
Ref 523193ClinicalTrials.gov (NCT01213472) Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.